Cargando…

Who do treatments work for and why? Understanding treatment-effect mechanisms in stratified medicine

Detalles Bibliográficos
Autores principales:	Emsley, Richard, Liu, Hanhua, Landau, Sabine, Dunn, Graham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980245/ http://dx.doi.org/10.1186/1745-6215-14-S1-O10

Ejemplares similares

Beyond total treatment effects in RCTs: why we need to measure outcomes at baseline when investigating mediation
por: Landau, Sabine, et al.
Publicado: (2015)

Combining multiple predictive markers in stratified medicine
por: Emsley, Richard, et al.
Publicado: (2015)

Designing trials of complex interventions for efficacy and mechanisms evaluation
por: Emsley, Richard A, et al.
Publicado: (2011)

Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
por: Malottki, Kinga, et al.
Publicado: (2011)

Patient safety: why do things go wrong?
por: Flin, R
Publicado: (2004)

How do we work with medical teams to provide optimal treatment for clients in the acute medical environment?
por: Stokes, Lisa, et al.
Publicado: (2014)

Beyond total treatment effects in randomised controlled trials: Baseline measurement of intermediate outcomes needed to reduce confounding in mediation investigations
por: Landau, Sabine, et al.
Publicado: (2018)

Understanding why edema in salvaged myocardium is difficult to detect by late gadolinium enhancement
por: Ugander, Martin, et al.
Publicado: (2012)

Statistical design of mental health complex intervention trials
por: Landau, Sabine
Publicado: (2011)

Stratified randomisation: a hidden form of clustering?
por: Kahan, Brennan C, et al.
Publicado: (2011)

If MIAVR is so good, why aren't we all doing it? A UK perspective
por: Smyth, Justin
Publicado: (2013)

Adaptive enrichment in biomarker-stratified clinical trial design
por: Parashar, Deepak, et al.
Publicado: (2013)

Type I error control in biomarker-stratified clinical trials
por: Parashar, Deepak, et al.
Publicado: (2015)

Who do we think we are: interdisciplinary dissonance and the development of professional identity
por: Barbaro-Brown, Judith
Publicado: (2010)

CMR to stratify post-TAVR paravalvular leak in patients with suboptimal echocardiography
por: Hartlage, Gregory, et al.
Publicado: (2014)

Psychiatry and the law: do the fields agree in their views on coercive treatment?
por: Arboleda-Florez, Julio
Publicado: (2007)

SBI and EHR: understanding, adoption, and implementation in family medicine clinics
por: Zoorob, Roger, et al.
Publicado: (2015)

A cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses?
por: Renner, Anna-Theresa, et al.
Publicado: (2015)

How to avoid one thousand opportunities to do harm in genomic medicine
por: Kohane, Isaac
Publicado: (2012)

Why measurements do (not) work: the human factor
por: Rameau, A, et al.
Publicado: (2014)

Pharmacogenomics of CRC treatments: putting bricks on the path to personalized medicine
por: Fernández-Rozadilla, Ceres, et al.
Publicado: (2014)

Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015)

Partial breast irradiation: why and how
por: Calvo, FA, et al.
Publicado: (2005)

The United Nations sustainable development goals, the WHO general program of work 2019-2023 and international safe communities
por: Hanson, Dale
Publicado: (2019)

Do practical food groups work in an eating disorders day program? Long term outcomes of repeated exposure
por: Wheatley, Jessica, et al.
Publicado: (2014)

How do treatments for chronic fatigue syndrome work? Exploration of instrumental variable methods for mediation analysis in PACE – a randomised controlled trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care
por: Goldsmith, Kimberley, et al.
Publicado: (2011)

O042: Study on adopting the WHO 5-moment of hand hygiene for practices in traditional Chinese medicine (TCM) clinics
por: Ching, P
Publicado: (2013)

Why allergen detection by ELISA is insufficient to protect allergic consumers
por: Popping, B
Publicado: (2013)

Growth hormone responsiveness: why does it vary and can it be predicted?
por: Cutfield, Wayne S
Publicado: (2015)

Joint Crisis Plans reduce coercive treatment
por: Henderson, Claire, et al.
Publicado: (2007)

If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine
por: Ehrenstein, Michael R., et al.
Publicado: (2007)

Understanding the mechanisms underlying phase-locking behavior in the crayfish swimmeret system
por: Lewis, Timothy J, et al.
Publicado: (2011)

Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities
por: Vogler, Sabine, et al.
Publicado: (2015)

Designing the CORONIS trial. Why a non-regular fractional factorial design?
por: Hardy, Pollyanna, et al.
Publicado: (2013)

40 years of anorexia nervosa: why we should never give up
por: Hill, Stephanie, et al.
Publicado: (2014)

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
por: Schelleman, Hedi, et al.
Publicado: (2015)

Understanding animal welfare
por: Fraser, David
Publicado: (2008)

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
por: Malattia, C, et al.
Publicado: (2011)

Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
por: Hall, Peter, et al.
Publicado: (2013)

Financial incentives for human resources for health: What do we know? What do we do? The case of Sierra Leone
por: Bertone, Maria Paola
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s9j0eec3b7di5qkbkhs7dlla2k